ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. Lifelong De Novo Aneurysm Risk After Ane…

Lifelong De Novo Aneurysm Risk After Aneurysmal Subarachnoid Hemorrhage in Young Survivors

JAMA Neurology·August 24
Clinical NeurologyPractice changingAneurysmal Subarachnoid HemorrhageIntracranial AneurysmProspective Cohort StudyAdultSmoking Cessation

Summary

View source

What was studied

This prospective cohort study examined the lifetime cumulative incidence, risk factors, and rupture rate of de novo intracranial aneurysm formation in 544 survivors of saccular aSAH who were younger than 40 years at the index event (1967–2014, Stockholm, Sweden), with radiological follow-up extending up to 57 years.

Key findings

Over 13,738 person-years, 19.5% (106/544) developed 158 de novo aneurysms; the 40-year Fine-Gray cumulative incidence was 30.2% (95% CI, 24.7%–35.7%) with no plateau. Independent risk factors were female sex (HR 1.76), smoking (HR 1.75), and family history (HR 2.17). The annual rupture rate was 153 per 100,000 person-years, but **no ruptures occurred under systematic surveillance**; one-third of ruptures happened >20 years post-index.

Study limitations

- Single-region (Stockholm) registry may limit generalizability to other populations. - Eligibility required original imaging/records, potentially introducing selection bias. - Smoking cessation data were observational; confounding cannot be excluded.

Clinical implications

Young aSAH survivors face a lifelong, non-plateauing risk of new aneurysm formation — counsel patients that risk extends well beyond 20 years. Prioritize smoking cessation as a modifiable target, and support lifelong radiological surveillance, especially in women and those with a family history.

Caveats

  • Smoking cessation association is based on observational data; dose-dependent relationship is noted but causality cannot be confirmed.
  • The cohort is restricted to patients under 40 years old at index event; findings may not apply to older aSAH survivors. Age-group tag reflects actual participant ages (median 33 years), not a pediatric population.
  • The modality/generic tag 'smoking cessation' is a behavioral intervention, not a drug — tagged for clinical relevance given explicit guideline implications discussed in the paper.

Related Questions

Explore related topics

What is the recommended surveillance interval for intracranial aneurysm screening after aneurysmal subarachnoid hemorrhage?How does smoking cessation reduce the risk of de novo aneurysm formation in SAH survivors?Which imaging modality is preferred for long-term aneurysm surveillance after subarachnoid hemorrhage?

Publication Details

Year
2026
Journal
JAMA Neurology
Sample Size
n=544
Source
View article
Keep scrolling
More content below.
Up Next